Effects of Taro (Colocasia esculenta) Water-Soluble Non-Starch Polysaccharide, Lactobacillus acidophilus, Bifidobacterium breve, Bifidobacterium infantis, and Their Synbiotic Mixtures on Pro-Inflammatory Cytokine Interleukin-8 Production

Nutrients. 2022 May 19;14(10):2128. doi: 10.3390/nu14102128.

Abstract

In the past decades, the regulation of pro-inflammatory cytokine production, including interleukin-8 (IL-8), has been the goal of many targeted therapeutic interventions for Necrotising enterocolitis (NEC), a gastrointestinal disease commonly associated with a very low birth weight in preterm infants. In this study, the ability to regulate the production of IL-8 of the water-soluble non-starch polysaccharide (WS-NSP) from taro corm (Tc-WS-NSP) extracted using a conventional (CE) or improved conventional (ICE) extraction method, of the probiotics Lactobacillus acidophilus, Bifidobacterium breve, and Bifidobacterium infantis, and their synbiotic mixtures were evaluated. The TNF-α stimulated HT-29 cells were incubated with undigested or digested Tc-WS-NSPs (CE or ICE), probiotics, and their synbiotic mixtures with Klebsiella oxytoca, an NEC-positive-associated pathogen. Overall, the synbiotic mixtures of digested Tc-WS-NSP-ICE and high bacterial concentrations of L. acidophilus (5.57 × 109), B. breve (2.7 × 108 CFU/mL), and B. infantis (1.53 × 108) demonstrated higher (42.0%, 45.0%, 43.1%, respectively) ability to downregulate IL-8 compared to the sole use of Tc-WS-NSPs (24.5%), or the probiotics L. acidophilus (32.3%), B. breve (37.8%), or B. infantis (33.1%). The ability demonstrated by the Tc-WS-NSPs, the probiotics, and their synbiotics mixtures to downregulate IL-8 production in the presence of an NEC-positive-associated pathogen may be useful in the development of novel prophylactic agents against NEC.

Keywords: interleukin 8; necrotising enterocolitis; probiotics; synbiotic; taro (Colocasia esculenta); water-soluble non-starch polysaccharide.

MeSH terms

  • Bifidobacterium
  • Bifidobacterium breve*
  • Bifidobacterium longum subspecies infantis
  • Colocasia*
  • Cytokines
  • Enterocolitis, Necrotizing* / prevention & control
  • Humans
  • Infant
  • Infant, Newborn
  • Infant, Premature
  • Interleukin-8
  • Lactobacillus acidophilus
  • Polysaccharides / pharmacology
  • Probiotics* / pharmacology
  • Probiotics* / therapeutic use
  • Synbiotics*
  • Water

Substances

  • Cytokines
  • Interleukin-8
  • Polysaccharides
  • Water

Grants and funding

This research received no external funding.